Literature DB >> 33692520

Bispecific antibodies poised to deliver wave of cancer therapies.

Cormac Sheridan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33692520     DOI： 10.1038/s41587-021-00850-6

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

1.  Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies.

Authors:  Yuanli Song; Hui Cai; Zhijun Tan; Nesredin Mussa; Zheng-Jian Li
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-24       Impact factor: 4.813

2.  A novel IgM intranasal intervention against SARS-CoV-2.

Authors:  Antony Yerabham; Mitchell Ho
Journal:  Antib Ther       Date:  2021-08-28

3.  A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization.

Authors:  Julia Harwardt; Jan P Bogen; Stefania C Carrara; Michael Ulitzka; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 4.  Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer.

Authors:  Tanya B Dorff; Vivek Narayan; Stephen J Forman; Peter D Zang; Joseph A Fraietta; Carl H June; Naomi B Haas; Saul J Priceman
Journal:  Clin Cancer Res       Date:  2022-02-15       Impact factor: 13.801

Review 5.  Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy.

Authors:  Hans Raskov; Adile Orhan; Shruti Gaggar; Ismail Gögenur
Journal:  Oncogenesis       Date:  2022-05-03       Impact factor: 6.524

6.  Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection.

Authors:  Daniel Klewinghaus; Lukas Pekar; Paul Arras; Simon Krah; Bernhard Valldorf; Harald Kolmar; Stefan Zielonka
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

7.  Detailed Analytical Characterization of a Bispecific IgG1 CrossMab Antibody of the Knob-into-Hole Format Applying Various Stress Conditions Revealed Pronounced Stability.

Authors:  Ingrid Grunert; Katrin Heinrich; Juliane Ernst; Michael Hingar; Alexandre Briguet; Michael Leiss; Manfred Wuhrer; Dietmar Reusch; Patrick Bulau
Journal:  ACS Omega       Date:  2022-01-19

8.  Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

Authors:  Jiayi Ye; Bo Hou; Fangmin Chen; Shunan Zhang; Muya Xiong; Tianliang Li; Yechun Xu; Zhiai Xu; Haijun Yu
Journal:  Acta Pharm Sin B       Date:  2021-09-25       Impact factor: 14.903

9.  An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics.

Authors:  Norbert Furtmann; Marion Schneider; Nadja Spindler; Bjoern Steinmann; Ziyu Li; Ingo Focken; Joachim Meyer; Dilyana Dimova; Katja Kroll; Wulf Dirk Leuschner; Audrey Debeaumont; Magali Mathieu; Christian Lange; Werner Dittrich; Jochen Kruip; Thorsten Schmidt; Joerg Birkenfeld
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.